These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration. Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang Z, Lin J, Li X, Guo Y. Oncotarget; 2015 Sep 22; 6(28):25856-67. PubMed ID: 26312564 [Abstract] [Full Text] [Related]
14. Correlation of IDH1 and B7H3 expression with prognosis of CRC patients. Wu J, Wang F, Liu X, Zhang T, Liu F, Ge X, Mao Y, Hua D. Eur J Surg Oncol; 2018 Aug 22; 44(8):1254-1260. PubMed ID: 29871819 [Abstract] [Full Text] [Related]
15. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis. Peng F, Li Q, Sun JY, Luo Y, Chen M, Bao Y. Int J Oncol; 2018 Mar 22; 52(3):945-954. PubMed ID: 29393396 [Abstract] [Full Text] [Related]
17. Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer. Wang Y, Song W, Feng C, Wu S, Qin Z, Liu T, Ye Y, Huang R, Xie Y, Tang Z, Wang Q, Li T. J Transl Med; 2024 Oct 04; 22(1):900. PubMed ID: 39367493 [Abstract] [Full Text] [Related]
18. GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy. Zhang Q, Zhuang J, Deng Y, Zhao X, Tang B, Yao D, Zhao W, Chang C, Lu Q, Chen W, Zhang S, Ji C, Cao L, Guo H. Oncotarget; 2015 Oct 13; 6(31):32177-92. PubMed ID: 26375441 [Abstract] [Full Text] [Related]
19. Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer. Tian DW, Wu ZL, Jiang LM, Gao J, Wu CL, Hu HL. Cancer Sci; 2019 Jan 13; 110(1):458-467. PubMed ID: 30407690 [Abstract] [Full Text] [Related]
20. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer. May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D. Clin Genitourin Cancer; 2014 Aug 13; 12(4):278-86. PubMed ID: 24331576 [Abstract] [Full Text] [Related] Page: [Next] [New Search]